ArticleJournal for immunotherapy of cancer2019

A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors.

Ezra E W Cohen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.